2.19
前日終値:
$2.32
開ける:
$2.39
24時間の取引高:
1.53M
Relative Volume:
0.31
時価総額:
$176.56M
収益:
$101.21M
当期純損益:
$-569.00K
株価収益率:
-109.50
EPS:
-0.02
ネットキャッシュフロー:
$-56.88M
1週間 パフォーマンス:
-8.37%
1か月 パフォーマンス:
-3.52%
6か月 パフォーマンス:
+157.65%
1年 パフォーマンス:
+58.70%
Cytomx Therapeutics Inc Stock (CTMX) Company Profile
名前
Cytomx Therapeutics Inc
セクター
電話
650.515.3185
住所
151 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
CTMX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
CTMX
Cytomx Therapeutics Inc
|
2.19 | 365.50M | 101.21M | -569.00K | -56.88M | -0.02 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Cytomx Therapeutics Inc Stock (CTMX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-05-15 | アップグレード | H.C. Wainwright | Neutral → Buy |
2025-04-14 | 再開されました | Piper Sandler | Overweight |
2024-05-28 | アップグレード | Piper Sandler | Neutral → Overweight |
2024-05-09 | アップグレード | Wedbush | Neutral → Outperform |
2024-05-06 | アップグレード | Jefferies | Hold → Buy |
2024-04-22 | アップグレード | JP Morgan | Underweight → Neutral |
2022-11-14 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
2022-07-07 | ダウングレード | Jefferies | Buy → Hold |
2022-07-07 | ダウングレード | Mizuho | Buy → Neutral |
2022-07-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
2022-07-07 | ダウングレード | Wedbush | Outperform → Neutral |
2022-06-24 | 開始されました | BMO Capital Markets | Outperform |
2022-01-18 | アップグレード | Barclays | Underweight → Overweight |
2021-11-15 | 開始されました | BTIG Research | Buy |
2021-05-28 | ダウングレード | Barclays | Equal Weight → Underweight |
2021-03-29 | 開始されました | JP Morgan | Overweight |
2021-03-23 | アップグレード | Jefferies | Hold → Buy |
2020-09-22 | ダウングレード | Guggenheim | Buy → Neutral |
2020-06-01 | ダウングレード | Jefferies | Buy → Hold |
2020-05-14 | 繰り返されました | H.C. Wainwright | Buy |
2020-03-24 | アップグレード | Wedbush | Neutral → Outperform |
2020-03-04 | 開始されました | Barclays | Equal Weight |
2019-11-20 | 開始されました | Guggenheim | Buy |
2019-11-11 | ダウングレード | Wedbush | Outperform → Neutral |
2019-06-13 | 開始されました | Mizuho | Buy |
2019-05-14 | 開始されました | Cantor Fitzgerald | Overweight |
2019-03-11 | 開始されました | Barclays | Overweight |
2018-11-26 | 開始されました | Piper Jaffray | Overweight |
2018-10-15 | 開始されました | Goldman | Neutral |
2018-09-13 | 開始されました | H.C. Wainwright | Buy |
2018-06-01 | 開始されました | SunTrust | Buy |
2018-01-05 | 開始されました | Citigroup | Buy |
2017-09-08 | 開始されました | Wedbush | Outperform |
2017-03-27 | 開始されました | H.C. Wainwright | Buy |
2017-03-02 | 開始されました | Instinet | Buy |
2017-01-03 | ダウングレード | Oppenheimer | Outperform → Perform |
2015-11-02 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Cytomx Therapeutics Inc (CTMX) 最新ニュース
What is the risk reward ratio of investing in CytomX Therapeutics Inc. stockFinancial News Planner For Consistent Profits - jammulinksnews.com
This Lexeo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday - Benzinga
How volatile is CytomX Therapeutics Inc. stock compared to the marketMarket Forecast Opportunities Backed By Experts - jammulinksnews.com
CytomX Therapeutics to Report Second Quarter 2025 Financial Results on August 7, 2025 | CTMX Stock News - GuruFocus
CytomX Therapeutics to Report Second Quarter 2025 Financial Results on August 7, 2025 - The Manila Times
CytomX Therapeutics Sets Q2 Earnings Date: Biotech Leader to Update on Masked Biologics Progress - Stock Titan
Oppenheimer initiates CytomX Therapeutics stock with Outperform rating By Investing.com - Investing.com Canada
How does CytomX Therapeutics Inc. compare to its industry peersEntry Signal Report For Beginners - jammulinksnews.com
Does CytomX Therapeutics Inc. stock perform well during market downturnsValue Investing Recommendation For Every Investor - jammulinksnews.com
What makes CytomX Therapeutics Inc. stock price move sharplyEntry Signal Report For Beginners - jammulinksnews.com
CytomX Therapeutics Inc. Reaches Critical Trendline SupportSwing Trade Entry With Volume Triggers Released - metal.it
Can CytomX Therapeutics Inc. hit a new high this monthIntraday Trend Analysis for Fast Gains Released - metal.it
CytomX Therapeutics Inc. Added to Custom Quant Screener TodayEntry and Exit Strategy Optimizer Tool Tested - metal.it
How strong is CytomX Therapeutics Inc. company’s balance sheetAI Powered Strategy For Beginners - jammulinksnews.com
What are analysts’ price targets for CytomX Therapeutics Inc. in the next 12 monthsFree Wealth Planning Blueprint - jammulinksnews.com
What institutional investors are buying CytomX Therapeutics Inc. stockGet expert analysis on top stock picks - jammulinksnews.com
What drives CytomX Therapeutics Inc. stock priceStrong return on assets - PrintWeekIndia
CytomX (CTMX) Shares Promising Early Results for CRC Drug Candidate - Yahoo Finance
What analysts say about CytomX Therapeutics Inc. stockSkyrocketing returns - PrintWeekIndia
CytomX Therapeutics Inc. Stock Analysis and ForecastExceptional return forecasts - Autocar Professional
10 Best Performing Penny Stocks So Far in 2025 - Insider Monkey
Is CytomX Therapeutics Inc. a good long term investmentFree Stock Market Return Analysis - Autocar Professional
Why CytomX Therapeutics Inc. stock attracts strong analyst attentionBalanced Risk Reward Portfolio - Newser
Cytomx Therapeutics Inc (CTMX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):